Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Decision on Cash/In-Kind Dividend / 2025-03-10 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Single Sales/Supply Contract / 2024-03-21 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Result of Action Such as Prosecution Referral for Violation of Accounting Standards / 2025-07-17 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Acquisition of Shares in Other Corporation / 2024-10-31 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-06-26 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Disclosure / 2026-07-09 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2024-07-18 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | Global Tier-1 Multiples · Passive-Substrate Synergy · Embedded & Si-Cap / 2026-05-26 RESEARCH

[Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2024-03-18

Posted on March 18, 2024August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Alteogen received an ‘Unqualified’ audit opinion from Ichon Accounting Corporation for both consolidated and separate financial statements, with consolidated revenue increasing significantly to KRW 96.5B compared to the previous fiscal year.

📊 [Key Disclosure Details & Financial Highlights]

  • Independent Auditor: Ichon Accounting Corporation (Date of Audit Report Receipt: March 18, 2024)
  • Audit Opinion (Consolidated & Separate): Unqualified (‘적정’)
    • Going Concern Uncertainty: No
    • Internal Accounting Control System Audit Opinion Deficiencies: No
  • Consolidated Financials & Performance (KRW):
    • Total Assets: 256,099,994,583 (Previous: 245,490,136,097)
    • Total Liabilities: 108,258,260,247 (Previous: 100,108,123,094)
    • Total Equity: 147,841,734,336 (Previous: 145,382,013,003) / Capital Stock: 26,505,914,000
    • Revenue: 96,522,928,887 (Previous: 28,806,344,498)
    • Operating Loss: -9,736,838,487 (Previous: -29,373,680,278)
    • Net Loss: -3,582,208,686 (Previous: -10,077,904,116)
  • Separate Financials & Performance (KRW):
    • Total Assets: 203,942,847,918 / Total Equity: 186,527,428,220
    • Revenue: 83,478,376,310 (Previous: 8,749,918,757)
    • Operating Loss: -904,325,264 (Previous: -21,470,898,108)
    • Net Income: 4,870,807,532 (Previous: 2,114,427,777)
  • Number of Consolidated Subsidiaries: 2 (Major Subsidiaries: 1)
  • Financial Requirement Checklist: Capital Impairment Rate: N/A / Loss Before Income Taxes to Equity Ratio: 2.4% / Impairment Loss Ratio >= 50%: No

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Why Verifying Unqualified Audit Opinion and Finalized Financial Metrics Is Necessary

This filing is an informational disclosure notifying the submission of the audit report, confirming that the fiscal year financial statements have received an ‘Unqualified’ opinion from the external auditor.

Checking this follow-up item is necessary because receiving an ‘Unqualified’ opinion establishes accounting reliability and officially finalizes the audited financial metrics. Verifying that the disclosed audit opinion and finalized financial figures are consistently incorporated into upcoming filings, such as the Annual Report following shareholders’ meeting approval, ensures the final verification of the disclosed facts.

The details can be verified in upcoming annual reports or future disclosures on DART.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Aerospace (012450) – Submission of Audit Report / 2024-03-18
Next Post: [Disclosure] LEENO Industrial (058470) – Submission of Audit Report / 2024-03-18

Related Posts

  • [Disclosure] SK Square (402340) – Matters Related to Obligatory Fair Disclosure / 2024-03-28 Semiconductors
  • [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2026-04-29 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding Announcement / 2024-04-17 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Acquisition of Shares and Investment Securities of Other Corporation (Correction Disclosure) / 2026-02-13 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2025-11-10 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Information Disclosure / 2025-11-21 Bio & Healthcare
  • [Disclosure] Hyundai Motor (005380) – Outlook on Operating Performance / 2026-01-05 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Loan to Related Party / 2024-11-21 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Major Business Report (Decision on Treasury Stock Acquisition) / 2025-02-18 Semiconductors
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Cash and In-Kind Dividend / 2024-01-25 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Issuance of Depositary Receipts (DR) (Correction) / 2026-07-10 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-04-25 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-12-02 Disclosures
  • [Disclosure] Celltrion (068270) – Change in Sales or Loss Structure by More Than 30% (15% for Large Corporations) / 2026-02-05 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme